Citations 21
Subgroup analysis of elderly patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial.
Younger, Eugenie , Pápai, Zsuzsanna , Tine, Brian Andrew Van, Attia, Steven , Lu, Yao , Schöffski, Patrick , Tap, William D. , Jones, Robin L. , Jones, Robin L , Ballman, Karla V. , Reinke, Denise K.
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 11575-11575
